🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/10/2016 44,91 45,40 40,02 40,81 -8,37% 11,98% 6.103.100
26/10/2016 46,54 46,54 44,36 44,54 -3,86% 4,68% 2.802.600
25/10/2016 47,17 48,58 46,30 46,33 -1,26% 4,83% 1.729.300
24/10/2016 47,91 48,26 46,85 46,92 -2,21% 2,94% 1.455.800
21/10/2016 48,10 48,70 47,51 47,98 -2,18% 2,47% 1.580.300
20/10/2016 47,66 49,37 46,77 49,05 +2,57% 5,46% 2.525.000
19/10/2016 49,21 49,68 47,73 47,82 -4,13% 3,96% 2.116.800
18/10/2016 50,00 51,38 49,06 49,88 +1,92% 4,64% 2.670.400
17/10/2016 52,27 52,50 48,39 48,94 -6,39% 7,86% 4.715.800
14/10/2016 54,34 55,02 52,15 52,28 -3,52% 5,28% 2.024.600
13/10/2016 53,24 54,94 52,93 54,19 +1,08% 3,78% 1.781.800
12/10/2016 53,56 56,32 52,30 53,61 -0,39% 7,51% 6.017.200
11/10/2016 56,89 57,35 53,35 53,82 -6,64% 7,03% 3.628.400
10/10/2016 58,43 58,70 56,51 57,65 -0,41% 3,75% 1.881.100
07/10/2016 61,55 61,99 55,72 57,89 -6,24% 10,19% 8.985.500
06/10/2016 62,15 63,03 61,45 61,74 -0,98% 2,54% 2.151.400
05/10/2016 61,24 62,79 60,82 62,35 +1,42% 3,22% 1.629.700
04/10/2016 61,45 62,13 60,56 61,48 +0,87% 2,55% 2.125.500
03/10/2016 61,69 61,80 60,10 60,95 -0,75% 2,76% 1.774.200
30/09/2016 61,17 62,23 59,60 61,41 +0,71% 4,30% 2.507.800
29/09/2016 62,24 63,10 60,12 60,98 -2,02% 4,79% 3.447.300
28/09/2016 61,80 63,73 60,57 62,24 +5,31% 5,11% 8.351.600
27/09/2016 59,05 59,94 57,71 59,10 -0,94% 3,78% 3.128.000
26/09/2016 59,01 61,43 58,00 59,66 +3,16% 5,81% 5.964.900
23/09/2016 60,51 60,70 57,23 57,83 -5,15% 5,73% 9.680.800
22/09/2016 56,90 61,60 56,90 60,97 +8,45% 8,26% 11.203.600
21/09/2016 57,58 58,87 54,60 56,22 +0,88% 7,42% 8.767.400
20/09/2016 51,95 56,80 51,95 55,73 +13,87% 9,34% 21.126.800
19/09/2016 28,81 56,18 28,10 48,94 +73,85% 97,47% 51.288.900
16/09/2016 29,40 29,93 27,99 28,15 -6,23% 6,60% 4.374.500